Patents by Inventor Clive T. R. Burge
Clive T. R. Burge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120003297Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: ApplicationFiled: February 1, 2011Publication date: January 5, 2012Applicant: TALON THERAPEUTICS, INC.Inventors: Andreas SARRIS, Fernando CABANILLAS, Patricia M. LOGAN, Clive T.R. BURGE, James H. GOLDIE, Murray S. WEBB
-
Patent number: 7887836Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: GrantFiled: March 7, 2008Date of Patent: February 15, 2011Assignees: Hana Biosciences, Inc., Board of Regents, The University of Texas SystemInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
-
Publication number: 20090041834Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: ApplicationFiled: March 7, 2008Publication date: February 12, 2009Applicants: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas SystemInventors: Andreas SARRIS, Fermando CABANILLAS, Patricia M. LOGAN, Clive T.R. BURGE, James H. GOLDIE, Murray S. WEBB
-
Patent number: 7311924Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.Type: GrantFiled: April 3, 2003Date of Patent: December 25, 2007Assignee: Hana Biosciences, Inc.Inventors: Andreas H Sarris, Fernando Cabanillas, Patricia M Logan, Clive T R Burge, James H Goldie, Murray S Webb, Thomas D Madden, Sean C Semple, Quet F Ahkong, Sandra K Klimuk
-
Patent number: 7247316Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: GrantFiled: February 18, 2004Date of Patent: July 24, 2007Assignees: Board of Regents, The University of Texas System, Inex Pharmaceuticals CorporationInventors: Andreas H Sarris, Fernando Cabanillas, Patricia M Logan, Clive T R Burge, James H Goldie, Murray S Webb
-
Patent number: 7244450Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: GrantFiled: December 4, 2003Date of Patent: July 17, 2007Assignees: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas SystemInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
-
Publication number: 20040253302Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: ApplicationFiled: December 4, 2003Publication date: December 16, 2004Applicants: Board of Regents, The University of Texas System, Inex Pharmaceuticals CorporationInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T.R. Burge, James H. Goldie, Murray S. Webb
-
Publication number: 20040228909Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: ApplicationFiled: February 18, 2004Publication date: November 18, 2004Applicants: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas SystemInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
-
Patent number: 6723338Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.Type: GrantFiled: March 31, 2000Date of Patent: April 20, 2004Assignees: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas SystemInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
-
Publication number: 20040071768Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.Type: ApplicationFiled: April 3, 2003Publication date: April 15, 2004Applicants: Inex Pharmaceuticals Corporation, The University of Texas, MD Anderson Cancer CenterInventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb, Thomas D. Madden, Sean C. Semple, Quet F. Ahkong, Sandra K. Klimuk
-
Publication number: 20030082228Abstract: The present invention provides methods and compositions for the treatment and prevention of any of a large number of diseases and conditions with an angiogenic component, e.g., cancer. The present invention is based upon the discovery that liposome-encapsulated chemotherapeutic agents, such as alkaloids (e.g., vinca alkaloids such as vincristine), are surprisingly effective at treating such diseases or conditions when administered at a higher frequency than those used with conventional administration strategies. Such methods can be used to treat diseases such as cancer even when the cancer comprises cells that are resistant to the chemotherapeutic alkaloid. The liposome encapsulation of the chemotherapeutic agents, e.g., alkaloids, imparts dramatic improvements in the stability, biodistribution, and delivery of the agents, thereby allowing more efficacious and convenient administration to a patient with any of the herein-described diseases or conditions.Type: ApplicationFiled: May 9, 2002Publication date: May 1, 2003Applicant: Inex Pharmaceuticals CorporationInventors: Clay Flowers, David Saltman, Patrick M.S. Tam, Clive T.R. Burge, Troy O. Hasrasym